Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S (January 2003). "Flecainide test in Brugada syndrome: a reproducible but risky tool". Pacing and Clinical Electrophysiology. 26 (1P2): 338–341. doi:10.1046/j.1460-9592.2003.00045.x. PMID12687841. S2CID555793.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (August 1989). "Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction". The New England Journal of Medicine. 321 (6): 406–412. doi:10.1056/NEJM198908103210629. PMID2473403.
Ohki R, Takahashi M, Mizuno O, Fujikawa H, Mitsuhashi T, Katsuki T, et al. (January 2001). "Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia". Pacing and Clinical Electrophysiology. 24 (1): 119–121. doi:10.1046/j.1460-9592.2001.00119.x. PMID11227957. S2CID41090195.
Morganroth J (February 1992). "Early and late proarrhythmia from antiarrhythmic drug therapy". Cardiovascular Drugs and Therapy. 6 (1): 11–14. doi:10.1007/BF00050910. PMID1533532. S2CID22653784.
Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (April 1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–1073. doi:10.1378/chest.103.4.1068. PMID8131440.
Fornieles-Pérez H, Montoya-García M, Levine PA, Sanz O (May 2002). "Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate". Pacing and Clinical Electrophysiology. 25 (5): 871–872. doi:10.1046/j.1460-9592.2002.00871.x. PMID12049386. S2CID7180036.
Camus P, Fanton A, Bonniaud P, Camus C, Foucher P (2004). "Interstitial lung disease induced by drugs and radiation". Respiration; International Review of Thoracic Diseases. 71 (4): 301–326. doi:10.1159/000079633. PMID15316202. S2CID16315007.
Pesenti S, Lauque D, Daste G, Boulay V, Pujazon MC, Carles P (2002). "Diffuse infiltrative lung disease associated with flecainide. Report of two cases". Respiration; International Review of Thoracic Diseases. 69 (2): 182–185. doi:10.1159/000056325. PMID11961436. S2CID72367121.
Robain A, Perchet H, Fuhrman C (February 2000). "Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome". Acta Cardiologica. 55 (1): 45–47. doi:10.2143/ac.55.1.2005718. PMID10707759. S2CID20721407.
Padrini R, Piovan D, Busa M, al-Bunni M, Maiolino P, Ferrari M (January 1993). "Pharmacodynamic variability of flecainide assessed by QRS changes". Clinical Pharmacology and Therapeutics. 53 (1): 59–64. doi:10.1038/clpt.1993.9. PMID8422742. S2CID23471140.
Sakurada H, Hiyoshi Y, Tejima T, Yanase O, Tokuyasu Y, Watanabe K, et al. (May 1990). "[Effects of oral flecainide treatment of refractory tachyarrhythmias]". Kokyu to Junkan. Respiration & Circulation. 38 (5): 471–476. PMID2115193.
Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S (January 2003). "Flecainide test in Brugada syndrome: a reproducible but risky tool". Pacing and Clinical Electrophysiology. 26 (1P2): 338–341. doi:10.1046/j.1460-9592.2003.00045.x. PMID12687841. S2CID555793.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators (August 1989). "Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction". The New England Journal of Medicine. 321 (6): 406–412. doi:10.1056/NEJM198908103210629. PMID2473403.
Ohki R, Takahashi M, Mizuno O, Fujikawa H, Mitsuhashi T, Katsuki T, et al. (January 2001). "Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia". Pacing and Clinical Electrophysiology. 24 (1): 119–121. doi:10.1046/j.1460-9592.2001.00119.x. PMID11227957. S2CID41090195.
Morganroth J (February 1992). "Early and late proarrhythmia from antiarrhythmic drug therapy". Cardiovascular Drugs and Therapy. 6 (1): 11–14. doi:10.1007/BF00050910. PMID1533532. S2CID22653784.
Santinelli V, Arnese M, Oppo I, Matarazzi C, Maione S, Palma M, Giunta A (April 1993). "Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function". Chest. 103 (4): 1068–1073. doi:10.1378/chest.103.4.1068. PMID8131440.
Fornieles-Pérez H, Montoya-García M, Levine PA, Sanz O (May 2002). "Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate". Pacing and Clinical Electrophysiology. 25 (5): 871–872. doi:10.1046/j.1460-9592.2002.00871.x. PMID12049386. S2CID7180036.
Camus P, Fanton A, Bonniaud P, Camus C, Foucher P (2004). "Interstitial lung disease induced by drugs and radiation". Respiration; International Review of Thoracic Diseases. 71 (4): 301–326. doi:10.1159/000079633. PMID15316202. S2CID16315007.
Pesenti S, Lauque D, Daste G, Boulay V, Pujazon MC, Carles P (2002). "Diffuse infiltrative lung disease associated with flecainide. Report of two cases". Respiration; International Review of Thoracic Diseases. 69 (2): 182–185. doi:10.1159/000056325. PMID11961436. S2CID72367121.
Haas M, Pérault MC, Bonnefoy P, Rodeau F, Caron F (2001). "[Interstitial pneumopathy due to flecainide]". Presse Médicale. 30 (21): 1062. PMID11471279.
Robain A, Perchet H, Fuhrman C (February 2000). "Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome". Acta Cardiologica. 55 (1): 45–47. doi:10.2143/ac.55.1.2005718. PMID10707759. S2CID20721407.
Padrini R, Piovan D, Busa M, al-Bunni M, Maiolino P, Ferrari M (January 1993). "Pharmacodynamic variability of flecainide assessed by QRS changes". Clinical Pharmacology and Therapeutics. 53 (1): 59–64. doi:10.1038/clpt.1993.9. PMID8422742. S2CID23471140.
Wang Z, Fermini B, Nattel S (November 1993). "Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue". The Journal of Pharmacology and Experimental Therapeutics. 267 (2): 575–581. PMID8246130.
Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S (January 2003). "Flecainide test in Brugada syndrome: a reproducible but risky tool". Pacing and Clinical Electrophysiology. 26 (1P2): 338–341. doi:10.1046/j.1460-9592.2003.00045.x. PMID12687841. S2CID555793.
Ohki R, Takahashi M, Mizuno O, Fujikawa H, Mitsuhashi T, Katsuki T, et al. (January 2001). "Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia". Pacing and Clinical Electrophysiology. 24 (1): 119–121. doi:10.1046/j.1460-9592.2001.00119.x. PMID11227957. S2CID41090195.
Morganroth J (February 1992). "Early and late proarrhythmia from antiarrhythmic drug therapy". Cardiovascular Drugs and Therapy. 6 (1): 11–14. doi:10.1007/BF00050910. PMID1533532. S2CID22653784.
Fornieles-Pérez H, Montoya-García M, Levine PA, Sanz O (May 2002). "Documentation of acute rise in ventricular capture thresholds associated with flecainide acetate". Pacing and Clinical Electrophysiology. 25 (5): 871–872. doi:10.1046/j.1460-9592.2002.00871.x. PMID12049386. S2CID7180036.
Camus P, Fanton A, Bonniaud P, Camus C, Foucher P (2004). "Interstitial lung disease induced by drugs and radiation". Respiration; International Review of Thoracic Diseases. 71 (4): 301–326. doi:10.1159/000079633. PMID15316202. S2CID16315007.
Pesenti S, Lauque D, Daste G, Boulay V, Pujazon MC, Carles P (2002). "Diffuse infiltrative lung disease associated with flecainide. Report of two cases". Respiration; International Review of Thoracic Diseases. 69 (2): 182–185. doi:10.1159/000056325. PMID11961436. S2CID72367121.
Robain A, Perchet H, Fuhrman C (February 2000). "Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome". Acta Cardiologica. 55 (1): 45–47. doi:10.2143/ac.55.1.2005718. PMID10707759. S2CID20721407.
Padrini R, Piovan D, Busa M, al-Bunni M, Maiolino P, Ferrari M (January 1993). "Pharmacodynamic variability of flecainide assessed by QRS changes". Clinical Pharmacology and Therapeutics. 53 (1): 59–64. doi:10.1038/clpt.1993.9. PMID8422742. S2CID23471140.